<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
MEdia Clips

CU Anschutz In The News


MDLinx

Time-to-hospital may be key to disparate results in studies on pre-hospital plasma administration

news outletMDLinx
Publish DateJuly 26, 2018

The findings mean "it's definitely feasible and it's safe to administer blood products such as frozen plasma" in a pre-hospital setting, COMBAT co-author Dr. Michael Chapman of the University of Colorado School of Medicine told Reuters Health in a telephone interview.

Full Story
PennLive.com

Does your doctor get big bucks from a drug company? These central Pa. docs receive $100,000+

news outletPennLive.com
Publish DateJuly 19, 2018

Research shows that doctors on the payrolls of drug or medical device companies are likely to prescribe that company's product -- even if it's not the best option for the patient, says Eric G. Campbell, director of research at the University of Colorado's Center for Bioethics and Humanities. Drug and device companies know this. It's one reason they collectively pay doctors and teaching hospitals about $3 billion a year.

Full Story
The Denver Post

Colorado veteran Spencer Milo battled invisible wounds of war after returning home

news outletThe Denver Post
Publish DateJuly 06, 2018

Today, Milo lives with his wife and two children in Castle Rock and serves as the director of veterans programs, communications and strategic development for the Marcus Institute for Brain Health (MIBH) at the University of Colorado Anschutz Medical Campus. Like the NICoE and its satellite Intrepid Spirit Centers across the country, the MIBH offers a model to treat mild to moderate brain injuries, post-traumatic stress, depression and anxiety. “Invisible injuries are so prevalent in the post 9/11 and war on terror,” Milo said.

Full Story
Longmont Times-Call

Boulder County experts say new medication could ease detox, but treatment mix still needed

news outletLongmont Times-Call
Publish DateMay 20, 2018

Lucemyra, also called lofexidine, was first developed as an antihypertensive drug to treat high blood pressure, but researchers discovered that it could also treat some of the withdrawal symptoms because it affects a neurotransmitter believed to cause a number of withdrawal symptoms, according to Robert Valuck, a professor at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences.

Full Story
FOX News

More parents smoking pot around kids, study finds

news outletFOX News
Publish DateMay 15, 2018

Even so, the findings underscore how legalization of cannabis in many U.S. states may reflect and reinforce more permissive attitudes about marijuana use, said Ashley Brooks-Russell, author of an accompanying editorial and a researcher at the Colorado School of Public Health at the University of Colorado Anschutz Medical Campus. "Cannabis legalization has increased the accessibility of cannabis for adults and removed many penalties for use," Brooks-Russell said by email. "It is possible these laws also convey a sense the product is safe, or at least safer than it once was perceived."

Full Story